| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 1.73e-05 | 11 | 96 | 3 | GO:0043139 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 7.64e-05 | 47 | 96 | 4 | GO:0051539 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.36e-04 | 4 | 96 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.26e-04 | 62 | 96 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.70e-04 | 127 | 96 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 5.45e-04 | 78 | 96 | 4 | GO:0051536 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 6.00e-04 | 80 | 96 | 4 | GO:0008186 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 6.29e-04 | 8 | 96 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | metal cluster binding | 6.89e-04 | 83 | 96 | 4 | GO:0051540 | |
| GeneOntologyMolecularFunction | helicase activity | 9.97e-04 | 158 | 96 | 5 | GO:0004386 | |
| Domain | GPS | 2.49e-05 | 34 | 94 | 4 | SM00303 | |
| Domain | GPS | 3.50e-05 | 37 | 94 | 4 | IPR000203 | |
| Domain | Guanylate_kinase_CS | 6.59e-05 | 16 | 94 | 3 | IPR020590 | |
| Domain | Helicase_C_2 | 1.49e-04 | 4 | 94 | 2 | PF13307 | |
| Domain | DEAD_2 | 1.49e-04 | 4 | 94 | 2 | PF06733 | |
| Domain | DEAD_2 | 1.49e-04 | 4 | 94 | 2 | IPR010614 | |
| Domain | ATP-dep_Helicase_C | 1.49e-04 | 4 | 94 | 2 | IPR006555 | |
| Domain | Helicase-like_DEXD_c2 | 1.49e-04 | 4 | 94 | 2 | IPR006554 | |
| Domain | DNA_helicase_DNA-repair_Rad3 | 1.49e-04 | 4 | 94 | 2 | IPR013020 | |
| Domain | HELICASE_ATP_BIND_2 | 1.49e-04 | 4 | 94 | 2 | PS51193 | |
| Domain | REJ | 1.49e-04 | 4 | 94 | 2 | PS51111 | |
| Domain | Helic_SF1/SF2_ATP-bd_DinG/Rad3 | 1.49e-04 | 4 | 94 | 2 | IPR014013 | |
| Domain | REJ_dom | 1.49e-04 | 4 | 94 | 2 | IPR014010 | |
| Domain | DEXDc2 | 1.49e-04 | 4 | 94 | 2 | SM00488 | |
| Domain | HELICc2 | 1.49e-04 | 4 | 94 | 2 | SM00491 | |
| Domain | GUANYLATE_KINASE_2 | 2.03e-04 | 23 | 94 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 2.03e-04 | 23 | 94 | 3 | PS00856 | |
| Domain | Guanylate_kin | 2.95e-04 | 26 | 94 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 2.95e-04 | 26 | 94 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 2.95e-04 | 26 | 94 | 3 | IPR008144 | |
| Domain | GuKc | 2.95e-04 | 26 | 94 | 3 | SM00072 | |
| Domain | ARM-type_fold | 3.11e-04 | 339 | 94 | 8 | IPR016024 | |
| Domain | PKD/REJ-like | 3.71e-04 | 6 | 94 | 2 | IPR002859 | |
| Domain | REJ | 3.71e-04 | 6 | 94 | 2 | PF02010 | |
| Domain | ARM-like | 4.28e-04 | 270 | 94 | 7 | IPR011989 | |
| Domain | GPS | 7.19e-04 | 35 | 94 | 3 | PF01825 | |
| Domain | GPS | 7.82e-04 | 36 | 94 | 3 | PS50221 | |
| Domain | - | 8.99e-04 | 222 | 94 | 6 | 1.25.10.10 | |
| Domain | Rap_GAP_dom | 1.34e-03 | 11 | 94 | 2 | IPR000331 | |
| Domain | RAPGAP | 1.34e-03 | 11 | 94 | 2 | PS50085 | |
| Domain | PKD_channel | 1.34e-03 | 11 | 94 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 1.34e-03 | 11 | 94 | 2 | IPR013122 | |
| Domain | EGF_dom | 1.60e-03 | 12 | 94 | 2 | IPR024731 | |
| Domain | EGF_3 | 1.60e-03 | 12 | 94 | 2 | PF12947 | |
| Domain | WW | 1.71e-03 | 47 | 94 | 3 | PF00397 | |
| Domain | WW | 1.81e-03 | 48 | 94 | 3 | SM00456 | |
| Domain | WW_DOMAIN_1 | 2.16e-03 | 51 | 94 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.16e-03 | 51 | 94 | 3 | PS50020 | |
| Domain | SEA | 2.19e-03 | 14 | 94 | 2 | SM00200 | |
| Domain | WW_dom | 2.28e-03 | 52 | 94 | 3 | IPR001202 | |
| Domain | - | 2.52e-03 | 15 | 94 | 2 | 3.30.70.960 | |
| Domain | Ig_I-set | 2.73e-03 | 190 | 94 | 5 | IPR013098 | |
| Domain | I-set | 2.73e-03 | 190 | 94 | 5 | PF07679 | |
| Domain | EGF_CA | 3.36e-03 | 122 | 94 | 4 | SM00179 | |
| Domain | P-loop_NTPase | MAGI1 BRIP1 ABCB5 MAGI3 DDX56 MSH5 DDX11 MAGI2 ATAD2B HFM1 HYDIN | 3.52e-03 | 848 | 94 | 11 | IPR027417 |
| Domain | EGF-like_Ca-bd_dom | 3.56e-03 | 124 | 94 | 4 | IPR001881 | |
| Domain | LH2 | 3.64e-03 | 18 | 94 | 2 | SM00308 | |
| Domain | - | 4.95e-03 | 21 | 94 | 2 | 2.60.60.20 | |
| Domain | PLAT | 4.95e-03 | 21 | 94 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 4.95e-03 | 21 | 94 | 2 | IPR001024 | |
| Domain | PLAT | 4.95e-03 | 21 | 94 | 2 | PS50095 | |
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 15509766 | ||
| Pubmed | Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins. | 1.17e-06 | 8 | 97 | 3 | 16316992 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 3.13e-06 | 36 | 97 | 4 | 26053890 | |
| Pubmed | 5.89e-06 | 13 | 97 | 3 | 23576434 | ||
| Pubmed | The mouse homologue of the polycystic kidney disease gene (Pkd1) is a single-copy gene. | 7.70e-06 | 2 | 97 | 2 | 8661056 | |
| Pubmed | MAGI-1: a widely expressed, alternatively spliced tight junction protein. | 7.70e-06 | 2 | 97 | 2 | 11969287 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24680660 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26055704 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34876325 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24683199 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 25355409 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34801967 | ||
| Pubmed | Acrofacial dysostosis in a patient with the TSC2-PKD1 contiguous gene syndrome. | 7.70e-06 | 2 | 97 | 2 | 11836366 | |
| Pubmed | Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells. | 7.70e-06 | 2 | 97 | 2 | 23523645 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 18060739 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 31176519 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 32855419 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 33712709 | ||
| Pubmed | MAGI1 copy number variation in bipolar affective disorder and schizophrenia. | 7.70e-06 | 2 | 97 | 2 | 22381734 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 8833153 | ||
| Pubmed | Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. | 7.70e-06 | 2 | 97 | 2 | 22941175 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 9013641 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 35142283 | ||
| Pubmed | Polycystin 1 is required for the structural integrity of blood vessels. | 7.70e-06 | 2 | 97 | 2 | 10677526 | |
| Pubmed | 9.34e-06 | 15 | 97 | 3 | 23782696 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 PTBP2 RALGAPB AGPAT3 MAGI3 NCAM2 DDX56 ZNF385B MSH5 ADGRV1 DOCK5 PXDN DPP9 SLC9A7 IFT122 | 1.58e-05 | 1489 | 97 | 15 | 28611215 |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 26163610 | ||
| Pubmed | Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study. | 2.31e-05 | 3 | 97 | 2 | 21792548 | |
| Pubmed | MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2. | 2.31e-05 | 3 | 97 | 2 | 32730644 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20373053 | ||
| Pubmed | A novel model for extrapleural cavity metastasis assessment in patients with lung cancer. | 2.31e-05 | 3 | 97 | 2 | 33709781 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 17611414 | ||
| Pubmed | Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9. | 2.31e-05 | 3 | 97 | 2 | 17852813 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 37088138 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 36581342 | ||
| Pubmed | Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis. | 2.31e-05 | 3 | 97 | 2 | 19321600 | |
| Pubmed | Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer. | 2.31e-05 | 3 | 97 | 2 | 34621407 | |
| Pubmed | Identification of MAGI-3 as a transforming growth factor-alpha tail binding protein. | 2.31e-05 | 3 | 97 | 2 | 15652357 | |
| Pubmed | Microtubule-bundling protein Spef1 enables mammalian ciliary central apparatus formation. | 2.31e-05 | 3 | 97 | 2 | 30535028 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 21854770 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GPD1 CEACAM5 ARMC3 ADGRV1 ENPP4 CUBN GDF2 LDHB RYR1 EML5 PKD1 NID1 | 2.64e-05 | 1016 | 97 | 12 | 19056867 |
| Pubmed | 2.83e-05 | 430 | 97 | 8 | 32581705 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 14566828 | ||
| Pubmed | Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer. | 4.60e-05 | 4 | 97 | 2 | 26560853 | |
| Pubmed | Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. | 4.60e-05 | 4 | 97 | 2 | 20169078 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 19255143 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 18845692 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 23362269 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 28011514 | ||
| Pubmed | 4.63e-05 | 25 | 97 | 3 | 23873930 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 11698076 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 19383238 | ||
| Pubmed | Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. | 7.66e-05 | 5 | 97 | 2 | 11818962 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 18609108 | ||
| Pubmed | Multiple roles of FOXJ3 in spermatogenesis: A lesson from Foxj3 conditional knockout mouse models. | 9.84e-05 | 32 | 97 | 3 | 27739607 | |
| Pubmed | Analysis of mouse embryonic patterning and morphogenesis by forward genetics. | 1.08e-04 | 33 | 97 | 3 | 15755804 | |
| Pubmed | 1.08e-04 | 33 | 97 | 3 | 19834762 | ||
| Pubmed | Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. | 1.15e-04 | 6 | 97 | 2 | 9647693 | |
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 1.18e-04 | 34 | 97 | 3 | 30726710 | |
| Pubmed | 1.29e-04 | 35 | 97 | 3 | 33864728 | ||
| Pubmed | 1.48e-04 | 407 | 97 | 7 | 12693553 | ||
| Pubmed | 1.55e-04 | 96 | 97 | 4 | 17971504 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 8828041 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 24025447 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 21896734 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.61e-04 | 552 | 97 | 8 | 10737800 | |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 37871017 | ||
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 22678773 | ||
| Pubmed | Analysis of the sperm flagellar axoneme using gene-modified mice. | 2.13e-04 | 8 | 97 | 2 | 32554934 | |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 9307024 | ||
| Pubmed | 2.56e-04 | 44 | 97 | 3 | 19322198 | ||
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 16805797 | ||
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 27889578 | ||
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 19071123 | ||
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 12446740 | ||
| Pubmed | DSCAM regulates delamination of neurons in the developing midbrain. | 4.17e-04 | 11 | 97 | 2 | 32917586 | |
| Pubmed | WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. | 4.21e-04 | 52 | 97 | 3 | 30655611 | |
| Pubmed | 4.45e-04 | 53 | 97 | 3 | 36265442 | ||
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 5.53e-04 | 134 | 97 | 4 | 28695742 | |
| Pubmed | Myc-dependent endothelial proliferation is controlled by phosphotyrosine 1212 in VEGF receptor-2. | 5.89e-04 | 13 | 97 | 2 | 31545012 | |
| Pubmed | Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase. | 6.41e-04 | 60 | 97 | 3 | 22889411 | |
| Pubmed | Systems genetic analysis of hippocampal neuroanatomy and spatial learning in mice. | 6.85e-04 | 14 | 97 | 2 | 26449520 | |
| Pubmed | MMS19 links cytoplasmic iron-sulfur cluster assembly to DNA metabolism. | 7.89e-04 | 15 | 97 | 2 | 22678361 | |
| Pubmed | EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos. | 7.89e-04 | 15 | 97 | 2 | 26576615 | |
| Pubmed | 9.30e-04 | 720 | 97 | 8 | 16381901 | ||
| Pubmed | 9.47e-04 | 722 | 97 | 8 | 15489336 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 1.03e-03 | 732 | 97 | 8 | 34732716 | |
| Pubmed | 1.12e-03 | 162 | 97 | 4 | 25826454 | ||
| Pubmed | Identification of novel human WW domain-containing proteins by cloning of ligand targets. | 1.14e-03 | 18 | 97 | 2 | 9169421 | |
| Pubmed | 1.21e-03 | 750 | 97 | 8 | 11230166 | ||
| Pubmed | Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. | 1.41e-03 | 293 | 97 | 5 | 31741433 | |
| Pubmed | 1.43e-03 | 79 | 97 | 3 | 25502805 | ||
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 1.48e-03 | 80 | 97 | 3 | 19389623 | |
| Pubmed | 1.56e-03 | 300 | 97 | 5 | 19086053 | ||
| Pubmed | 1.56e-03 | 21 | 97 | 2 | 21703454 | ||
| Pubmed | Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease. | 1.56e-03 | 21 | 97 | 2 | 27591083 | |
| Pubmed | 1.59e-03 | 446 | 97 | 6 | 24255178 | ||
| Pubmed | 1.71e-03 | 22 | 97 | 2 | 35081489 | ||
| Pubmed | 1.71e-03 | 22 | 97 | 2 | 27582005 | ||
| Pubmed | 1.73e-03 | 794 | 97 | 8 | 11076863 | ||
| Cytoband | 10p12.31 | 9.93e-04 | 22 | 97 | 2 | 10p12.31 | |
| Cytoband | 3q22.3 | 1.28e-03 | 25 | 97 | 2 | 3q22.3 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.19e-04 | 26 | 67 | 3 | 904 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.26e-04 | 161 | 67 | 5 | 593 | |
| GeneFamily | DEAD-box helicases | 5.04e-04 | 42 | 67 | 3 | 499 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.56e-04 | 181 | 67 | 5 | 694 | |
| GeneFamily | DNA helicases | 1.77e-03 | 17 | 67 | 2 | 1167 | |
| GeneFamily | PDZ domain containing | 2.44e-03 | 152 | 67 | 4 | 1220 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.50e-10 | 191 | 96 | 9 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-10 | 199 | 96 | 9 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.75e-09 | 188 | 96 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.75e-09 | 188 | 96 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 9.14e-09 | 192 | 96 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 9.14e-09 | 192 | 96 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.91e-09 | 194 | 96 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-08 | 195 | 96 | 8 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-08 | 199 | 96 | 8 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-08 | 199 | 96 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.34e-07 | 181 | 96 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.44e-07 | 183 | 96 | 7 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.61e-07 | 186 | 96 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.67e-07 | 187 | 96 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.73e-07 | 188 | 96 | 7 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.93e-07 | 191 | 96 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.93e-07 | 191 | 96 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.00e-07 | 192 | 96 | 7 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.00e-07 | 192 | 96 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.00e-07 | 192 | 96 | 7 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-07 | 195 | 96 | 7 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-07 | 199 | 96 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.31e-07 | 148 | 96 | 6 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-06 | 166 | 96 | 6 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.74e-06 | 168 | 96 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-06 | 169 | 96 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.51e-06 | 179 | 96 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.68e-06 | 181 | 96 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 2.85e-06 | 183 | 96 | 6 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-06 | 183 | 96 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 3.04e-06 | 185 | 96 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 3.04e-06 | 185 | 96 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.04e-06 | 185 | 96 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.04e-06 | 185 | 96 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 3.13e-06 | 186 | 96 | 6 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-06 | 187 | 96 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.54e-06 | 190 | 96 | 6 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.54e-06 | 190 | 96 | 6 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.65e-06 | 191 | 96 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.65e-06 | 191 | 96 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.65e-06 | 191 | 96 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.65e-06 | 191 | 96 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.65e-06 | 191 | 96 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.65e-06 | 191 | 96 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Control-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 3.76e-06 | 192 | 96 | 6 | f95fb188aa642f3d0618242a770e7c4b70544adb | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.76e-06 | 192 | 96 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.76e-06 | 192 | 96 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 3.88e-06 | 193 | 96 | 6 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.88e-06 | 193 | 96 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.88e-06 | 193 | 96 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.88e-06 | 193 | 96 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.99e-06 | 194 | 96 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 3.99e-06 | 194 | 96 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.11e-06 | 195 | 96 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.11e-06 | 195 | 96 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.11e-06 | 195 | 96 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 195 | 96 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 4.24e-06 | 196 | 96 | 6 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 4.24e-06 | 196 | 96 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 4.24e-06 | 196 | 96 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.36e-06 | 197 | 96 | 6 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-06 | 198 | 96 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 4.49e-06 | 198 | 96 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.49e-06 | 198 | 96 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-06 | 199 | 96 | 6 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-06 | 199 | 96 | 6 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-06 | 199 | 96 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.76e-06 | 200 | 96 | 6 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.76e-06 | 200 | 96 | 6 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.76e-06 | 200 | 96 | 6 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 138 | 96 | 5 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_Naive|ICU-SEP / Disease, Lineage and Cell Type | 1.79e-05 | 149 | 96 | 5 | a66f3ebf6214b269b137ddd5f4d8d7fb3ef2d962 | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.90e-05 | 151 | 96 | 5 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.90e-05 | 151 | 96 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 155 | 96 | 5 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.67e-05 | 162 | 96 | 5 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.75e-05 | 163 | 96 | 5 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.83e-05 | 164 | 96 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.14e-05 | 83 | 96 | 4 | 3aa95bf2d8ac37e648037faf3d54ebb243a4fde1 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.14e-05 | 83 | 96 | 4 | 70804dd63221dd5ed26068ec1b50f11875abbc50 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.14e-05 | 83 | 96 | 4 | c1818411438f53aec76afead5c8caab701b95d39 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.14e-05 | 83 | 96 | 4 | 1e7af8aaa20b4c2a77cf2f330113db0faa9d483c | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.36e-05 | 170 | 96 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.55e-05 | 172 | 96 | 5 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 175 | 96 | 5 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 175 | 96 | 5 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 175 | 96 | 5 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.97e-05 | 176 | 96 | 5 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.97e-05 | 176 | 96 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.07e-05 | 177 | 96 | 5 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 179 | 96 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.30e-05 | 179 | 96 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.30e-05 | 179 | 96 | 5 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.30e-05 | 179 | 96 | 5 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 179 | 96 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 179 | 96 | 5 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.41e-05 | 180 | 96 | 5 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.41e-05 | 180 | 96 | 5 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 4.41e-05 | 180 | 96 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.41e-05 | 180 | 96 | 5 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| Disease | Congenital Hydrocephalus | 1.79e-06 | 8 | 95 | 3 | C0020256 | |
| Disease | Malignant neoplasm of breast | BRIP1 UBR4 CUBN PKDREJ SPAG6 LDHB SLC25A51 IFNA2 EPG5 NF1 ZFYVE26 PLD2 MRPL9 TP53BP2 | 8.64e-06 | 1074 | 95 | 14 | C0006142 |
| Disease | Polycystic kidneys, severe infantile with tuberous sclerosis | 1.03e-05 | 2 | 95 | 2 | C1838327 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | mucocutaneous lymph node syndrome | 1.08e-04 | 76 | 95 | 4 | EFO_0004246 | |
| Disease | mental or behavioural disorder, substance abuse | 1.53e-04 | 6 | 95 | 2 | EFO_0000677, MONDO_0002491 | |
| Disease | Cerebral ventriculomegaly | 2.13e-04 | 7 | 95 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 2.13e-04 | 7 | 95 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 2.13e-04 | 7 | 95 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 2.13e-04 | 7 | 95 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 2.13e-04 | 7 | 95 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 2.13e-04 | 7 | 95 | 2 | C0549423 | |
| Disease | Aqueductal Stenosis | 2.84e-04 | 8 | 95 | 2 | C2936786 | |
| Disease | Hydrocephalus | 3.64e-04 | 9 | 95 | 2 | C0020255 | |
| Disease | cancer antigen 125 measurement | 4.54e-04 | 10 | 95 | 2 | EFO_0010603 | |
| Disease | pursuit maintenance gain measurement | 6.83e-04 | 123 | 95 | 4 | EFO_0008433 | |
| Disease | vision disorder | 1.20e-03 | 16 | 95 | 2 | MONDO_0021084 | |
| Disease | melanoma | 1.26e-03 | 248 | 95 | 5 | C0025202 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 1.35e-03 | 17 | 95 | 2 | C1839839 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.36e-03 | 148 | 95 | 4 | C0279702 | |
| Disease | thyroid peroxidase antibody measurement | 1.64e-03 | 72 | 95 | 3 | EFO_0005666 | |
| Disease | urinary microalbumin measurement | 1.88e-03 | 20 | 95 | 2 | EFO_0010967 | |
| Disease | lung cancer | 2.07e-03 | 21 | 95 | 2 | MONDO_0008903 | |
| Disease | Leukemia, Myelocytic, Acute | 2.40e-03 | 173 | 95 | 4 | C0023467 | |
| Disease | Septicemia | 2.70e-03 | 24 | 95 | 2 | C0036690 | |
| Disease | Sepsis | 2.70e-03 | 24 | 95 | 2 | C0243026 | |
| Disease | Severe Sepsis | 2.70e-03 | 24 | 95 | 2 | C1719672 | |
| Disease | West Syndrome | 2.70e-03 | 24 | 95 | 2 | C0037769 | |
| Disease | Pyemia | 2.70e-03 | 24 | 95 | 2 | C0034189 | |
| Disease | platelet component distribution width | 3.05e-03 | 755 | 95 | 8 | EFO_0007984 | |
| Disease | cortical thickness | MON2 ANKRD13B MAGI1 PTBP2 ZNF385B ADGRV1 BTBD1 TENM2 PKD1 PLXNA2 | 3.11e-03 | 1113 | 95 | 10 | EFO_0004840 |
| Disease | methionine measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0009771 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 3.17e-03 | 26 | 95 | 2 | EFO_0007870 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLQQHSIPVFIFSAG | 191 | Q9H0P0 | |
| GAVTVFFLQKPHLQI | 236 | A0FGR9 | |
| KFQFTPTHVGLQRLT | 651 | P16452 | |
| PFIQIKVLHNPSGVF | 496 | Q9HCE0 | |
| VTIGQPHLLNKFNFV | 2191 | Q96N23 | |
| LIFIAFMFQLQGIHP | 1071 | Q9H7T0 | |
| LFQVTGDPHFNIVIT | 811 | Q6L9W6 | |
| LTHPINTFEPIKVQF | 261 | Q6ZNB7 | |
| LNGTVHPVFSIIFAK | 701 | Q2M3G0 | |
| NKVTPLHFLVAQGSV | 361 | Q8NFD2 | |
| GIPQQHTQVLFIAKI | 631 | P06731 | |
| DFLLVGIFPTTVHLQ | 1301 | Q8WXG9 | |
| LKFQLKSNVIPIGHV | 776 | Q5W041 | |
| IFQKVQHSFETPNIL | 306 | Q6UXS9 | |
| HTEIVKFLVQFGVNV | 971 | Q13625 | |
| FPFQKHILLFNISIP | 126 | Q9UK05 | |
| LFILNPHTGQLFVNV | 646 | Q9NPG4 | |
| KVVSVFNTLIFPLHN | 271 | A0A0X1KG70 | |
| IPIFHILNARITFGN | 421 | Q86YJ7 | |
| GLPIKQVFHELSQQT | 14006 | Q8WXI7 | |
| STFPVHRQKLQGFVV | 581 | Q9HBG6 | |
| THAQVVKIFQSIPIG | 531 | Q96QZ7 | |
| HADVVKLFQSVPIGQ | 486 | Q86UL8 | |
| THLQVVEVLKQFPVG | 631 | Q5TCQ9 | |
| ITHFERLQQKTGIPF | 101 | Q86V88 | |
| SFNNILAVLQKVFPH | 686 | Q9ULI0 | |
| ENHTNQPFFIKTIVL | 621 | Q8N448 | |
| LTFVLPTEQFHLGKI | 386 | Q9NY93 | |
| VIKNPQFVFDIHKGS | 1751 | O75051 | |
| NLKPHIQGIIQDVIF | 341 | O95373 | |
| PKFRSIVHAVQAGIF | 116 | P54750 | |
| EVTFVGHPGNLVIKQ | 521 | P14543 | |
| FPHLQNFIKEGVLVE | 46 | Q9Y6X5 | |
| IFATAHSPIGIIIQN | 341 | P63132 | |
| VHPQLDVVFKAVQGL | 386 | Q0VAA2 | |
| LIQIFPALYQHIKTG | 1276 | Q7Z3U7 | |
| KFLLLNPAVHFAQVV | 596 | Q96FC9 | |
| FFIAVLGHTPEAVQI | 101 | Q8WWR8 | |
| TLQFAVHIPTFVLGL | 21 | Q9Y2T6 | |
| TFPILQGHFSAVLQK | 486 | Q9BX63 | |
| TKLPQQAGNAVIVHF | 1351 | A2PYH4 | |
| RTFVLNFIKIPVVPH | 356 | P04070 | |
| LQGFATPVFQHLQVV | 91 | Q5W5W9 | |
| APVNKVIHLTFNTFA | 3191 | O60494 | |
| KAEIVFQFTPFHLGI | 4041 | Q4G0P3 | |
| ISLIGDIKFQHFNPV | 701 | Q9H7D0 | |
| LQAIVSHFQKLFDVP | 466 | Q8NHQ1 | |
| PGLQFFIVIVSDHQK | 146 | Q8WXQ3 | |
| AAVVIFGPLLQFHVN | 61 | A5D6W6 | |
| GLIVNKAPHDFQFVQ | 46 | Q86TI2 | |
| QGVKFSVFIHQPRAL | 386 | Q9BPX7 | |
| VNLFLHFTVNPKPRV | 301 | Q9H0C5 | |
| FLLLNPAVHFAQVVK | 616 | Q92771 | |
| ADILIFVVPHQFIGK | 86 | P21695 | |
| FGNQFQKAETIPVLH | 66 | P01563 | |
| HPVFQTGAKVTFLLE | 881 | O75578 | |
| LQHGSLFLQTPKIVA | 66 | P07195 | |
| VIVKIPFQSHLPIQA | 566 | Q86VF2 | |
| TVNQHPKFINIVATG | 1421 | Q05BV3 | |
| GFNVINHPIRVFTLN | 111 | Q8IXS0 | |
| VLFFLVGFAQQTLKP | 11 | P59796 | |
| KLFPAVFVLPTHQNV | 1546 | P21817 | |
| INEHVSGPFVQFFVK | 371 | Q9H6A0 | |
| SKVVAPGQLVHFQIL | 1896 | P98161 | |
| QFILVGFSVFPHLQL | 11 | Q9Y4A9 | |
| KVPFIHVGNQVVSEL | 71 | O75431 | |
| PHIFVATNFLSLVQL | 701 | O43196 | |
| PNILKHVVGQFSKVL | 426 | O75602 | |
| PVTLDVLHQIFSKFG | 191 | Q9UKA9 | |
| RQFHAEKEIIFQGPI | 1226 | O15061 | |
| LNKLFTHTIVPGQVL | 141 | Q8NI08 | |
| FFKVGSQLEVLVHVQ | 116 | Q969Y0 | |
| GFLFFPINVVKTRIQ | 226 | Q9H1U9 | |
| HQNPVTLFTVLFIIL | 1181 | Q9NTG1 | |
| VRHIFTIPGQAFVPK | 206 | Q8WVM0 | |
| IHISQPQFLKFNISL | 471 | Q9NT68 | |
| GIFVPNSNIVHIFSA | 121 | Q9BSK2 | |
| KQVHISFLPANTQGF | 501 | Q8NFU7 | |
| PGTNLVFHIIFAILN | 1241 | Q8IZF2 | |
| PEIVARHFFKNLGVV | 186 | Q9BYD2 | |
| KVQTLQFHPFEAQTL | 301 | Q13610 | |
| PKLVISVHGGIQNFT | 136 | Q9BX84 | |
| FLKTQFVLHLLVGFV | 6 | Q9NRZ7 | |
| EKQAFLQVFVQPHII | 291 | O15394 | |
| GFFVKLIHIPINNII | 51 | P60059 | |
| QPFVVETLHGKIAVA | 106 | Q06203 | |
| VHATAFIIVQALPQF | 421 | Q92626 | |
| ASVVFPKVFPVVHNL | 2646 | P21359 | |
| VQKAVINHTFGVSIP | 136 | Q569K4 | |
| VIFIHPLNTGLFRIK | 1391 | Q86X10 | |
| NSQGHKFFRKIIPAV | 381 | Q658L1 | |
| LVFHPTSLFAIQVNI | 201 | Q9Y2C9 | |
| QKHVFSPIFIIGAFV | 436 | Q96T83 | |
| VLHPQLATGNFIIKA | 1991 | Q5T4S7 | |
| LTQVQGHLVHFPLKF | 896 | O14939 | |
| HVEVKVGNPFVLLQQ | 1176 | Q68DK2 | |
| HRKSVFFVGQLEAPQ | 1696 | Q562E7 | |
| TIKGQFNFVHVIVTP | 1661 | P49815 |